Metabolic Engineering And In Vitro Biosynthesis Of Phytochemicals And Non-Natural Analogues

Plant Science

Volumn 210, Issue , 2013, Pages 10-24

  Mora Pale, Mauricio ^a   Sanchez Rodriguez, Sandra P ^a   Linhatrdt, Robert J ^a,b,c   Dordick, Jonathan S ^a,b   Koffas, Mattheos A G ^a,c  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^b Rensselaer Polytechnic Institute   (United States)

^c RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

Alkaloids; Flavonoids; Metabolic engineering; Phytochemicals; Recombinant microogranisms; Synthetic biology; Terpenoids

Indexed keywords

ALKALOID; BIOLOGICAL PRODUCT; FLAVONOID; PLANT MEDICINAL PRODUCT; STILBENE DERIVATIVE; TERPENE;

CHEMISTRY; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; METABOLIC ENGINEERING; METABOLISM; PLANT; PLANT CELL; RECOMBINANT MICROOGRANISMS; REVIEW; SACCHAROMYCES CEREVISIAE; SYNTHETIC BIOLOGY; TERPENOIDS;

ALKALOIDS; FLAVONOIDS; METABOLIC ENGINEERING; PHYTOCHEMICALS; RECOMBINANT MICROOGRANISMS; SYNTHETIC BIOLOGY; TERPENOIDS;

ALKALOIDS; BIOLOGICAL PRODUCTS; ESCHERICHIA COLI; FLAVONOIDS; GENE EXPRESSION; METABOLIC ENGINEERING; METABOLIC NETWORKS AND PATHWAYS; PHYTOCHEMICALS; PLANT CELLS; PLANTS; SACCHAROMYCES CEREVISIAE; STILBENES; SYNTHETIC BIOLOGY; TERPENES;

EID: 84879172594     PISSN: 01689452     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plantsci.2013.05.005     Document Type: Review

References (135)

1. Petronilho S., Maraschin M., Coimbra M.A., Rocha S.M. In vitro and in vivo studies of natural products: a challenge for their valuation. The case study of chamomile (Matricaria recutita L.). Ind. Crop. Prod. 2012, 40:1-12.
2. Schmid Pocket Guide to Biotechnology and Genetic Engineering 2003, Cambridge, Weinheim.
3. Baker D.D., Chu M., Oza U., Rajgarhia V. The value of natural products to future pharmaceutical discovery. Nat. Prod. Rep. 2007, 24:1225-1244.
4. Chemler J.A., Yan Y.J., Koffas M.A.G. Biosynthesis of isoprenoids, polyunsaturated fatty acids and flavonoids in Saccharomyces cerevesiae. Microb. Cell Fact. 2006, 5:5.
5. Ladiwala A.R.A., et al. Polyphenolic glycosides and aglycones utilize opposing pathways to selectively remodel and inactivate toxic oligomers of amyloid beta. ChemBiochem. 2011, 12:1749-1758.
6. Mora-Pale M., Kwon S.J., Linhardt R.J., Dordick J.S. Trimer hydroxylated quinone derived from apocynin targets cysteine residues of p47(phox) preventing the activation of human vascular NADPH oxidase. Free Radical Biol. Med. 2012, 52:962-969.
7. Mora-Pale M., Weiwer M., Yu J., Linhardt R.J., Dordick J.S. Inhibition of human vascular NADPH oxidase by apocynin derived oligophenols. Bioorg. Med. Chem. 2009, 17:5146-5152.
8. Kwon S.J., Mora-Pale M., Lee M.-Y., Dordick J.S. Expanding nature's small molecule diversity via in vitro biosynthetic pathway engineering. Curr. Opin. Chem. Biol. 2012, 16:186-195.
9. Shao Z., Zhao H., Zhao H. DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways. Nucleic Acids Res. 2009, 37:e16.
10. Shao Z., Zhao H. DNA assembler: a synthetic biology tool for characterizing and engineering natural product gene clusters. Methods Enzymol. 2012, 517:203-224.
11. Shao Z., Luo Y., Zhao H. DNA assembler method for construction of zeaxanthin-producing strains of Saccharomyces cerevisiae. Methods Mol. Biol. (Clifton, N.J.) 2012, 898:251-262.
12. Xu P., Vansiri A., Bhan N., Koffas M.A.G. ePathBrick: a synthetic biology platform for engineering metabolic pathways in E. coli. ACS Synth. Biol. 2012, 1:256-266.
13. Koffas M., Stephanopoulos G. Strain improvement by metabolic engineering: lysine production as a case study for systems biology. Curr. Opin. Biotechnol. 2005, 16:361-366.
14. Stephanopoulos G., Alper H., Moxley J. Exploiting biological complexity for strain improvement through systems biology. Nat. Biotechnol. 2004, 22:1261-1267.
15. Fowler Z.L., Gikandi W.W., Koffas M.A.G. Increased malonyl coenzyme A biosynthesis by tuning the Escherichia coli metabolic network and its application to flavanone production. Appl. Environ. Microbiol. 2009, 75:5831-5839.
16. Boghigian B.A., Armando J., Salas D., Pfeifer B.A. Computational identification of gene over-expression targets for metabolic engineering of taxadiene production. Appl. Microbiol. Biotechnol. 2012, 93:2063-2073.
17. Agger S., Lopez-Gallego F., Schmidt-Dannert C. Diversity of sesquiterpene synthases in the basidiomycete Coprinus cinereus. Mol. Microbiol. 2009, 72:1181-1195.
18. Cao R., et al. Diterpene cyclases and the nature of the isoprene fold. Proteins Struct. Funct. Bioinf. 2010, 78:2417-2432.
19. Meng H., Wang Y., Hua Q., Zhang S., Wang X. In silico analysis and experimental improvement of taxadiene heterologous biosynthesis in Escherichia coli. Biotechnol. Bioprocess Eng. 2011, 16:205-215.
20. Chang M.C.Y., Eachus R.A., Trieu W., Ro D.-K., Keasling J.D. Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat. Chem. Biol. 2007, 3:274-277.
21. Zurbriggen A., Kirst H., Melis A. Isoprene production via the mevalonic acid pathway in Escherichia coli (Bacteria). Bioenergy Res. 2012, 5:814-828.
22. Zhou Y.J., et al. Modular pathway engineering of diterpenoid synthases and the mevalonic acid pathway for miltiradiene production. J. Am. Chem. Soc. 2012, 134:3234-3241.
23. Hoeffler J.F., Tritsch D., Grosdemange-Billiard C., Rohmer M. Isoprenoid biosynthesis via the methylerythritol phosphate pathway. Eur. J. Biochem. 2002, 269:4446-4457.
24. Ajikumar P.K., et al. Isoprenoid pathway optimization for taxol precursor overproduction in Escherichia coli. Science. 2010, 330:70-74.
25. Boghigian B.A., Salas D., Ajikumar P.K., Stephanopoulos G., Pfeifer B.A. Analysis of heterologous taxadiene production in K- and B-derived Escherichia coli. Appl. Microbiol. Biotechnol. 2012, 93:1651-1661.
26. Jiang M., Stephanopoulos G., Pfeifer B.A. Toward biosynthetic design and implementation of Escherichia coli-derived paclitaxel and other heterologous polyisoprene compounds. Appl. Environ. Microbiol. 2012, 78:2497-2504.
27. Jiang M., Stephanopoulos G., Pfeifer B.A. Downstream reactions and engineering in the microbially reconstituted pathway for Taxol. Appl. Microbiol. Biotechnol. 2012, 94:841-849.
28. Lim P., et al. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malaria J. 2009, 8:11.
29. Abdin M.Z., Israr M., Rehman R.U., Jain S.K. Artemisinin, a novel antimalarial drug: biochemical and molecular approaches for enhanced production. Planta Med. 2003, 2003(69):289-299.
30. Bertea C.M., et al. Identification of intermediates and enzymes involved in the early steps of artemisinin biosynthesis in Artemisia annua. Planta Med. 2005, 71:40-47.
31. Teoh K.H., Polichuk D.R., Reed D.W., Nowak G., Covello P.S. Artemisia annua L. (Asteraceae) trichome-specific cDNAs reveal CYP71AV1, a cytochrome P450 with a key role in the biosynthesis of the antimalarial sesquiterpene lactone artemisinin. FEBS Lett. 2006, 580:1411-1416.
32. Lindahl A.L., et al. Production of the artemisinin precursor amorpha-4,11-diene by engineered Saccharomyces cerevisiae. Biotechnol. Lett. 2006, 28:571-580.
33. Tsuruta H., et al. High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli. PLoS One 2009, 4.
34. Westfall P.J., et al. Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:111-118.
35. Vannelli T., Qi W.W., Sweigard J., Gatenby A.A., Sariaslani F.S. Production of p-hydroxycinnamic acid from glucose in Saccharomyces cerevisiae and Escherichia coli by expression of heterologous genes from plants and fungi. Metab. Eng. 2007, 9:142-151.
36. Dixon R.A., Steele C.L. Flavonoids and isoflavonoids - a gold mine for metabolic engineering. Trends Plant Sci. 1999, 4:394-400.
37. Jiang H.X., Wood K.V., Morgan J.A. Metabolic engineering of the phenylpropanoid pathway in Saccharomyces cerevisiae. Appl. Environ. Microbiol. 2005, 71:2962-2969.
38. Leonard E., Chemler J., Lim K.H., Koffas M.A.G. Expression of a soluble flavone synthase allows the biosynthesis of phytoestrogen derivatives in Escherichia coli. Appl. Microbiol. Biotechnol. 2006, 70:85-91.
39. Leonard E., Yan Y.J., Lim K.H., Koffas M.A.G. Investigation of two distinct flavone synthases for plant-specific flavone biosynthesis in Saccharomyces cerevisiae. Appl. Environ. Microbiol. 2005, 71:8241-8248.
40. Katsuyama Y., Funa N., Miyahisa I., Horinouchi S. Synthesis of unnatural flavonoids and stilbenes by exploiting the plant biosynthetic pathway in Escherichia coli. Chem. Biol. 2007, 14:613-621.
41. Malla S., Koffas M.A.G., Kazlauskas R.J., Kim B.-G. Production of 7-O-methyl aromadendrin, a medicinally valuable flavonoid, in Escherichia coli. Appl. Environ. Microbiol. 2012, 78:684-694.
42. Chemler J.A., Lock L.T., Koffas M.A.G., Tzanakakis E.S. Standardized biosynthesis of flavan-3-ols with effects on pancreatic beta-cell insulin secretion. Appl. Microbiol. Biotechnol. 2007, 77:797-807.
43. Santos C.N.S., Koffas M., Stephanopoulos G. Optimization of a heterologous pathway for the production of flavonoids from glucose. Metab. Eng. 2011, 13:392-400.
44. Ververidis F., et al. Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health. Biotechnol. J. 2007, 2:1214-1234.
45. A. Bedekar, K. Shah, M. Koffas, Natural products for type II diabetes treatment. In: Edited by,Advances in Applied Microbiology, vol. 71, 2010:21-73.
46. Fowler Z.L., Shah K., Panepinto J.C., Jacobs A., Koffas M.A.G. Development of non-natural flavanones as antimicrobial agents. PLoS One 2011, 6:1-5.
47. Chemler J.A., Lim C.G., Daiss J.L., Koffas M.A.G. A versatile microbial system for biosynthesis of novel polyphenols with altered estrogen receptor binding activity. Chem. Biol. 2010, 17:392-401.
48. - binding motif on AEn-related proteins to stimulate mitogenesis. Eur. J. Immunol. 1992, 22:1165-1171.
49. Wight R.D., et al. Resveratrol effects on astrocyte function: relevance to neurodegenerative diseases. Biochem. Biophys. Res. Commun. 2012, 426:112-115.
50. Park C.E., et al. Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase. Exp. Mol. Med. 2007, 39:222-229.
51. Dasgupta B., Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:7217-7222.
52. Ladiwala A.R.A., et al. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid A beta into off-pathway conformers. J. Biol. Chem. 2010, 285:24228-24237.
53. Wang Y., et al. Stepwise increase of resveratrol biosynthesis in yeast Saccharomyces cerevisiae by metabolic engineering. Metab. Eng. 2011, 13:455-463.
54. Becker J.V.W., et al. Metabolic engineering of Saccharomyces cerevisiae for the synthesis of the wine-related antioxidant resveratrol. FEMS Yeast Res. 2003, 4:79-85.
55. Lee H., DeLoache W.C., Dueber J.E. Spatial organization of enzymes for metabolic engineering. Metab. Eng. 2012, 14:242-251.
56. Wang Y., Yu O. Synthetic scaffolds increased resveratrol biosynthesis in engineered yeast cells. J. Biotechnol. 2011, 157:258-260.
57. Bhan N., Xu P., Khalidi O., Koffas M.A.G. Redirecting carbon flux into malonyl-CoA to improve resveratrol titers: proof of concept for genetic interventions predicted by OptForce computational framework. Chem. Eng. Sci. 2013, in press.
58. Nascimento N.C., Fett-Neto A.G. Plant secondary metabolism and challenges in modifying its operation: an overview. Methods Mol. Biol. 2010, 643:1-13.
59. Lambert E., Faizal A., Geelen D. Modulation of triterpene saponin production: in vitro cultures, elicitation, and metabolic engineering. Appl. Biochem. Biotechnol. 2011, 164:220-237.
60. Khan M.Y., Aliabbas S., Kumar V., Rajkumar S. Recent advances in medicinal plant biotechnology. Indian J. Biotechnol. 2009, 8:9-22.
61. Vongpaseuth K., Roberts S.C. Advancements in the understanding of paclitaxel metabolism in tissue culture. Curr. Pharm. Biotechnol. 2007, 8:219-236.
62. Malik S., et al. Production of the anticancer drug taxol in Taxus baccata suspension cultures: a review. Process Biochem. 2011, 46:23-34.
63. Patil R.A., Kolewe M.E., Normanl J., Walker E.L., Roberts S.C. Contribution of taxane biosynthetic pathway gene expression to observed variability in paclitaxel accumulation in Taxus suspension cultures. Biotechnol. J. 2012, 7:418-427.
64. Lenka S.K., et al. Identification and expression analysis of methyl jasmonate responsive ESTs in paclitaxel producing Taxus cuspidata suspension culture cells. BMC Genomics 2012, 13.
65. Exposito O., et al. Metabolic responses of Taxus media transformed cell cultures to the addition of methyl jasmonate. Biotechnol. Prog. 2010, 26:1145-1153.
66. Gao M., Zhang W., Li X., Ruan C., Fan S. Expression profiling of genes involved in Taxuyunnanine C biosynthesis in cell suspension cultures of Taxus chinensis by repeated elicitation with a newly synthesized jasmonate and sucrose feeding. Chinese J. Biotechnol. 2011, 27:101-107.
67. Roberts S.C. Production and engineering of terpenoids in plant cell culture. Nat. Chem. Biol. 2007, 3:387-395.
68. Nims E., Dubois C.P., Roberts S.C., Walker E.L. Expression profiling of genes involved in paclitaxel biosynthesis for targeted metabolic engineering. Metab. Eng. 2006, 8:385-394.
69. Kai G., et al. Metabolic engineering tanshinone biosynthetic pathway in Salvia miltiorrhiza hairy root cultures. Metab. Eng. 2011, 13:319-327.
70. Graham I.A., et al. The genetic map of Artemisia annua L. identifies loci affecting yield of the antimalarial drug artemisinin. Science 2010, 327:328-331.
71. Morgan J.A., Shanks J.V. Quantification of metabolic flux in plant secondary metabolism by a biogenetic organizational approach. Metab. Eng. 2002, 4:257-262.
72. Verma A., Laakso I., Seppanen-Laakso T., Huhtikangas A., Riekkola M.-L. A simplified procedure for indole alkaloid extraction from Catharanthus roseus combined with a semi-synthetic production process for vinblastine. Molecules 2007, 12:1307-1315.
73. Ishikawa H., et al. Total synthesis of vinblastine, vincristine, related natural products, and key structural analogues. J. Am. Chem. Soc. 2009, 131:4904-4916.
74. Gotoh H., Duncan K.K., Robertson W.M., Boger D.L. 10'-fluorovinblastine and 10'-fluorovincristine: synthesis of a key series of modified vinca alkaloids. ACS Med. Chem. Lett. 2011, 2:948-952.
75. Monks N.R., et al. Natural products genomics: a novel approach for the discovery of anti-cancer therapeutics. J. Pharmacol. Toxicol. Methods 2011, 64:217-225.
76. Runguphan W., Qu X., O'Connor S.E. Integrating carbon-halogen bond formation into medicinal plant metabolism. Nature 2010, 468:461-464.
77. Larkin P.J., et al. Fist, Increasing morphinan alkaloid production by over-expressing codeinone reductase in transgenic Papaver somniferum. Plant Biotechnol. J. 2007, 5:26-37.
78. Frick S., Kramell R., Kutchan T.M. Metabolic engineering with a morphine biosynthetic P450 in opium poppy surpasses breeding. Metab. Eng. 2007, 9:169-176.
79. Leonard E., Runguphan W., O'Connor S., Prather K.J. Opportunities in metabolic engineering to facilitate scalable alkaloid production. Nat. Chem. Biol. 2009, 5:292-300.
80. Allen R.S., et al. RNAi-mediated replacement of morphine with the nonnarcotic alkaloid reticuline in opium poppy. Nat. Biotechnol. 2004, 22:1559-1566.
81. Glenn W.S., Runguphan W., O'Connor S.E. Recent progress in the metabolic engineering of alkaloids in plant systems. Curr. Opin. Biotechnol. 2013, 24:354-365.
82. Gantet P., Memelink J. Transcription factors: tools to engineer the production of pharmacologically active plant metabolites. Trends Pharmacol. Sci. 2002, 23:563-569.
83. Park N.I., Xu H., Li X., Kim S.-J., Park S.U. Enhancement of flavone levels through overexpression of chalcone isomerase in hairy root cultures of Scutellaria baicalensis. Funct. Integr. Genomics 2011, 11:491-496.
84. Zhang Y., et al. Cloning and expression analysis of peanut (Arachis hypogaea L.) CHI gene. Electron. J. Biotechnol. 2011, 15.
85. Fornale S., et al. ZmMYB31 directly represses maize lignin genes and redirects the phenylpropanoid metabolic flux. Plant J. 2010, 64:633-644.
86. Nishiyama Y., et al. Expression of bacterial tyrosine ammonia-lyase creates a novel p-coumaric acid pathway in the biosynthesis of phenylpropanoids in Arabidopsis. Planta 2010, 232:209-218.
87. Meyer J.E., Pepin M.F., Smith M.A.L. Anthocyanin production from Vaccinium pahalae: limitations of the physical micro environment. J. Biotechnol. 2002, 93:45-57.
88. Sugiyama A., et al. Metabolic engineering for the production of prenylated polyphenols in transgenic legume plants using bacterial and plant prenyltransferases. Metab. Eng. 2011, 13:629-637.
89. Donnez D., Jeandet P., Clement C., Courot E. Bioproduction of resveratrol and stilbene derivatives by plant cells and microorganisms. Trends Biotechnol. 2009, 27:706-713.
90. Giovinazzo G., Ingrosso I., Paradiso A., De Gara L., Santino A. Resveratrol biosynthesis: plant metabolic engineering for nutritional improvement of food. Plant Foods Human Nutr. 2012, 67:191-199.
91. Liu S., Hu Y., Wang X., Zhong J., Lin Z. High content of resveratrol in lettuce transformed with a stilbene synthase gene of Parthenocissus henryana. J. Agric. Food. Chem. 2006, 54:8082-8085.
92. Belhadj A., et al. Effect of methyl jasmonate in combination with carbohydrates on gene expression of PR proteins, stilbene and anthocyanin accumulation in grapevine cell cultures. Plant Physiol. Biochem. 2008, 46:493-499.
93. Ferri M., et al. Chitosan treatment induces changes of protein expression profile and stilbene distribution in Vitis vinifera cell suspensions. Proteomics 2009, 9:610-624.
94. Zamboni A., Vrhovsek U., Kassemeyer H.H., Mattivi F., Velasco R. Elicitor-induced resveratrol production in cell cultures of different grape genotypes (Vitis spp.). Vitis 2006, 45:63-68.
95. Lucas-Abellan C., Fortea I., Lopez-Nicolas J.M., Nunez-Delicado E. Cyclodextrins as resveratrol carrier system. Food Chem. 2007, 104:39-44.
96. Belchi-Navarro S., Almagro L., Lijavetzky D., Bru R., Pedreno M.A. Enhanced extracellular production of trans-resveratrol in Vitis vinifera suspension cultured cells by using cyclodextrins and methyljasmonate. Plant Cell Rep. 2012, 31:81-89.
97. Jeandet P., et al. Metabolic engineering of yeast and plants for the production of the biologically active hydroxystilbene, resveratrol. J. Biomed. Biotechnol. 2012.
98. Kiselev K.V., et al. The rolB gene-induced overproduction of resveratrol in Vitis amurensis transformed cells. J. Biotechnol. 2007, 128:681-692.
99. Kizer L., Pitera D.J., Pfleger B.F., Keasling J.D. Application of functional genomics to pathway optimization for increased isoprenoid production. Appl. Environ. Microbiol. 2008, 74:3229-3241.
100. Fischbach M.A., Walsh C.T. Assembly-line enzymology for polyketide and nonribosomal peptide antibiotics: logic, machinery, and mechanisms. Chem. Rev. 2006, 106:3468-3496.
101. Wilkinson B., Micklefield J. Mining and engineering natural-product biosynthetic pathways. Nat. Chem. Biol. 2007, 3:379-386.
102. Thulasiram H.V., Erickson H.K., Poulter C.D. Chimeras of two isoprenoid synthases catalyze all four coupling reactions in isoprenoid biosynthesis. Science 2007, 316:73-76.
103. Erickson H.K., Poulter C.D. Chrysanthemyl diphosphate synthase. The relationship among chain elongation, branching, and cyclopropanation reactions in the isoprenoid biosynthetic pathway. J. Am. Chem. Soc. 2003, 125:6886-6888.
104. Thulasiram H.V., Erickson H.K., Poulter C.D. A common mechanism for branching, cyclopropanation, and cyclobutanation reactions in the isoprenoid biosynthetic pathway. J. Am. Chem. Soc. 2008, 130:1966-1971.
105. Heaps N.A., Poulter C.D. Synthesis and evaluation of chlorinated substrate analogues for farnesyl diphosphate synthase. J. Org. Chem. 2011, 76:1838-1843.
106. Koeksal M., Hu H., Coates R.M., Peters R.J., Christianson D.W. Structure and mechanism of the diterpene cyclase ent-copalyl diphosphate synthase. Nat. Chem. Biol. 2011, 7:431-433.
107. Koeksal M., Jin Y., Coates R.M., Croteau R., Christianson D.W. Taxadiene synthase structure and evolution of modular architecture in terpene biosynthesis. Nature 2011, 469:116-138.
108. Khmelnitsky Y.L., et al. Synthesis of water-soluble paclitaxel derivatives by enzymatic acylation. J. Am. Chem. Soc. 1997, 119:11554-11555.
109. Lodeiro S., et al. An oxidosqualene cyclase makes numerous products by diverse mechanisms: a challenge to prevailing concepts of triterpene biosynthesis. J. Am. Chem. Soc. 2007, 129:11213-11222.
110. Lopez-Gallego F., Agger S.A., Abate-Pella D., Distefano M.D., Schmidt-Dannert C. Sesquiterpene synthases Cop4 and Cop6 from Coprinus cinereus: catalytic promiscuity and cyclization of farnesyl pyrophosphate geometric isomers. ChemBioChem. 2010, 11:1093-1106.
111. Lopez-Gallego F., Wawrzyn G., Schmidt-Dannert C. Selectivity of fungal sesquiterpene synthases: role of the active site's H-1alpha loop in catalysis. Appl. Environ. Microbiol. 2010, 76:7723-7733.
112. Yoshikuni Y., Ferrin T.E., Keasling J.D. Designed divergent evolution of enzyme function. Nature 2006, 440:1078-1082.
113. Degenhardt J., Köllner T.G., Gershenzon J. Monoterpene and sesquiterpene synthases and the origin of terpene skeletal diversity in plants. Phytochemistry 2009, 70:1621-1637.
114. Little D.B., Croteau R.B. Alteration of product formation by directed mutagenesis and truncation of the multiple-product sesquiterpene synthases delta-selinene synthase and gamma-humulene synthase. Arch. Biochem. Biophys. 2002, 402:120-135.
115. Kanegae M.P.P., et al. Diapocynin versus apocynin as pretranscriptional inhibitors of NADPH oxidase and cytokine production by peripheral blood mononuclear cells. Biochem. Biophys. Res. Comm. 2010, 393:551-554.
116. Antoniotti S., Santhanam L., Ahuja D., Hogg M.G., Dordick J.S. Structural diversity of peroxidase-catalyzed oxidation products of o-methoxyphenols. Org. Lett. 2004, 6:1975-1978.
117. Snyder S.A., Gollner A., Chiriac M.I. Regioselective reactions for programmable resveratrol oligomer synthesis. Nature 2011, 474:461-466.
118. Elmarakby S.A., Duffel M.E., Goswami A., Sariaslani F.S., Rosazza J.P.N. In vitro metabolic transformations of vinblastine: oxidations catalyzed by peroxidase. J. Med. Chem. 1989, 32:674-679.
119. Werner S.R., Morgan J.A. Expression of a Dianthus flavonoid glucosyltransferase in Saccharomyces cerevisiae for whole-cell biocatalysis. J. Biotechnol. 2009, 142:233-241.
120. Han X., Ren D., Fan P., Shen T., Lou H. Protective effects of naringenin-7-O-glucoside on doxorubicin-induced apoptosis in H9C2 cells. Eur. J. Pharmacol. 2008, 581:47-53.
121. Ren G., et al. Synthesis of flavonol 3-O-glycoside by UGT78D1. Glycoconjugate J. 2012, 29:425-432.
122. Shim H., Hong W.P., Ahn Y. Enzymatic preparation of phenolic glucosides by Streptococcus mutans. Bull. Korean Chem. Soc. 2003, 24:1680-1682.
123. Mathew S., Hedström M., Adlercreutz P. Enzymatic synthesis of piceid glycosides by cyclodextrin glucanotransferase. Process Biochem. 2012, 47:528-532.
124. Orsini F., Pelizzoni F., Verotta L., Aburjai T., Rogers C.B. Isolation, synthesis, and antiplatelet aggregation activity of resveratrol 3-O-I-d-glucopyranoside and related compounds. J. Nat. Prod. 1997, 60:1082-1087.
125. Du J., et al. Lipid-lowering effects of polydatin from Polygonum cuspidatum in hyperlipidemic hamsters. Phytomedicine 2009, 16:652-658.
126. Arichi H., et al. Effects of stilbene components of the roots of Polygonum-Cuspidatum Sieb Et Zucc on lipid-metabolism. Chem. Pharm. Bull. 1982, 30:1766-1770.
127. Alves-Rodrigues A., Shao A. The science behind lutein. Toxicol. Lett. 2004, 150:57-83.
128. Tyczkowski J.K., Hamilton P.B. Preparation of purified lutein and its diesters from extracts of Marigold (Tagetes erecta). Poultry Sci. 1991, 70:651-654.
129. Mora-Pale M., Perez-Munguia S., Gonzalez-Mejia J.C., Dordick J.S., Barzana E. The lipase-catalyzed hydrolysis of lutein diesters in non-aqueous media is favored at extremely low water activities. Biotechnol. Bioeng. 2007, 98:535-542.
130. Kobata K., et al. Lipase-catalyzed synthesis of capsaicin analogs by transacylation of capsaicin with natural oils or fatty acid derivatives in n-hexane. Biotechnol. Lett. 1999, 21:547-550.
131. Liu K.-J. Lipase-catalyzed synthesis and antibacterial activity of N-vanillylnonanamide. J. Mol. Catal. B: Enzym. 2009, 58:181-186.
132. Nordblad M., Adlercreutz P. Efficient enzymatic acrylation through transesterification at controlled water activity. Biotechnol. Bioeng. 2008, 99:1518-1524.
133. Kim M.I., Kwon S.J., Dordick J.S. In vitro precursor-directed synthesis of polyketide analogues with coenzyme A regeneration for the development of antiangiogenic agents. Org. Lett. 2009, 11:3806-3809.
134. Kwon S.J., Lee M.-Y., Ku B., Sherman D.H., Dordick J.S. High-throughput, microarray-based synthesis of natural product analogues via in vitro metabolic pathway construction. ACS Chem. Biol. 2007, 2:419-425.
135. Jenkins T., Bovi A., Edwards R. Plants: biofactories for a sustainable future?. Philos. Trans. R. Soc. London, Ser. A 2011, 369:1826-1839.